•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A06210 Summary:

BILL NOA06210
 
SAME ASSAME AS S06180
 
SPONSORWeprin
 
COSPNSRDavila
 
MLTSPNSR
 
Amd §19.07, Ment Hyg L
 
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
Go to top    

A06210 Actions:

BILL NOA06210
 
04/03/2023referred to alcoholism and drug abuse
01/03/2024referred to alcoholism and drug abuse
Go to top

A06210 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A6210
 
SPONSOR: Weprin
  TITLE OF BILL: An act to amend the mental hygiene law, in relation to requiring the office of addiction services and supports to encourage, aid, and facili- tate clinical research into the use of ibogaine in drug treatment   PURPOSE: To encourage and fund clinical research examining Ibogaine as a possible pharmacotherapy that would suppress the craving for cocaine, methamphe- tamine, and heroin quickly and at a lower cost than current treatment methods.   SUMMARY OF PROVISIONS: The bill amends section 19.07 of the Mental Hygiene Law and requires the Division of Substance Abuse Services to encourage, aid, and facilitate clinical research into the use of Ibogaine in drug treatment.   RATIONALE: Like many other states, New York has seen significant impact from the current heroin and cocaine epidemic in America. Among the most promising treatments in development is Ibogaine, a medication derived from an African botanical which has been shown to eliminate narcotic withdrawal and interrupt self-administration of drugs of abuse. Over the past 20 years, thousands of American addicts have traveled to Mexican clinics for treatment with Ibogaine. Returning addicts report they experienced no withdrawal symptoms and that cravings to use drugs were absent. Dr. Kenneth Alper of New York University reported the emer- gence of Ibogaine as a part of a growing medical subculture. (Journal of Ethno-Pharmacology, 115: pp 924).   JUSTIFICATION: New York researchers have taken the lead in conducting research evaluat- ing Ibogaine. The Chairman of the Department of Pharmacology of Albany Medical College, Dr. Stanley Glick, reported that Ibogaine eliminated acute signs of opiate withdrawal in the animal model (Neuropharmacology 31: 5 pp. 497-500). He further reported that it also interrupted self- administration of morphine (European Journal of Pharmacology, 195:pp 341-345) as well as cocaine self-administration (Brain Research, 657: pp 14-22). Dr. Henry Sershen of the Nathan Klein Institute of Psychiatric Research in Orangeburg, NY reported that Ibogaine reduces preference for cocaine consumption (Pharmacology Biochemistry and Behavior, 46:pp 942-948). Dr. Patricia Broderick of the City University of New York Medical School, Department of Pharmacology, demonstrated that the effects of Ibogaine are consistent with current views regarding rational strategies for cocaine treatment. NIDA Research Monograph Series 119.   FISCAL IMPLICATIONS: To be determined.   LEGISLATIVE HISTORY: 02/09/17 referred to alcoholism and drug abuse 01/03/18 referred-to alcoholism and drug abuse 02/01/19referred to alcoholism and drug abuse 01/08/20referred to alcoholism and drug abuse
Go to top

A06210 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          6210
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                      April 3, 2023
                                       ___________
 
        Introduced by M. of A. WEPRIN -- read once and referred to the Committee
          on Alcoholism and Drug Abuse
 
        AN  ACT  to  amend  the mental hygiene law, in relation to requiring the
          office of addiction services  and  supports  to  encourage,  aid,  and
          facilitate  clinical  research into the use of ibogaine in drug treat-
          ment

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Section  19.07  of  the  mental hygiene law is amended by
     2  adding a new subdivision (o) to read as follows:
     3    (o) The office of addiction services  and  supports  shall  encourage,
     4  aid,  and  facilitate clinical research into the use of ibogaine in drug
     5  treatment for heroin, methamphetamine and cocaine addiction.
     6    § 2. This act shall take effect immediately.
 
 
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10569-01-3
Go to top